LanCL1 protects prostate cancer cells from oxidative stress via suppression of JNK pathway

Prostate cancer (PCa) is the most commonly diagnosed malignancy in male. Numerous studies have focused on the molecular mechanisms of carcinogenesis and progression, aiming at developing new therapeutic strategies. Here we describe Lanthionine synthase C-like protein 1 (LanCL1), a member of the LanC...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cell Death Dis
Autors principals: Wang, Jianqing, Xiao, Qianyi, Chen, Xu, Tong, Shijun, Sun, Jianliang, Lv, Ruitu, Wang, Siqing, Gou, Yuancheng, Tan, Li, Xu, Jianfeng, Fan, Caibin, Ding, Guanxiong
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group UK 2018
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5833716/
https://ncbi.nlm.nih.gov/pubmed/29416001
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41419-017-0207-0
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars